TLPH
Talphera, Inc.
There isn't enough reported data to score TLPH yet.
TLPH Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Unavailable | |
| Unavailable |
TLPH's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
TLPH PE Valuation
TLPH has no meaningful PE right now: it lost money over the past year.
TLPH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| -- | |
| Limited | |
| High |
Analysts expect TLPH's losses to shrink, with revenue holding steady.
TLPH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.24 | +$0.13 |
| Q2 2026 | -$0.30 | +$0.09 |
| Q1 2026 | -$0.34 | +$0.10 |
| Q4 2025 | -$0.40 | +$0.10 |
| Q3 2025 | -$0.37 | +$0.34 |
| Q2 2025 | -$0.39 | +$0.27 |
| Q1 2025 | -$0.44 | +$0.47 |
| Q4 2024 | -$0.50 | +$1.00 |
TLPH is still losing money, but far less than before: $0.24 per share over the past year, against $14.00 at its worst in early 2020.
TLPH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $281K | +12% |
| Q3 2023 | $117K | -77% |
| Q2 2023 | $253K | -56% |
| Q4 2022 | $252K | +12500% |
| Q3 2022 | $507K | -73% |
| Q2 2022 | $570K | +29% |
| Q1 2022 | $442K | -14% |
| Q4 2021 | $2K | -100% |
TLPH's revenue has slid since its 2020 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2025 | -342200% | N/A |
| Q1 2025 | -10800% | N/A |
| Q4 2023 | -1524% | +1425 points |
| Q3 2023 | -2828% | -1520 points |
| Q2 2023 | -1569% | +813 points |
| Q4 2022 | -2950% | +405800 points |
| Q3 2022 | -1308% | -844 points |
| Q2 2022 | -2381% | -121 points |
TLPH's operating margin was −342200% last quarter, down 340631 points from the same quarter a year ago, near the bottom of its range since 2019.
TLPH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3M | -$524K |
| Q2 2026 | -$3.9M | -$976K |
| Q1 2026 | -$3.4M | +$70K |
| Q4 2025 | -$2.4M | -$182K |
| Q3 2025 | -$2.5M | +$426K |
| Q2 2025 | -$2.9M | +$1.7M |
| Q1 2025 | -$3.5M | -$587K |
| Q4 2024 | -$2.3M | +$1.7M |
TLPH has burned cash in almost every quarter: −$13M over the past year, against −$11M the year before.
TLPH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +17.1K shares |
| 1 year | +82% | +34.1M shares |
| 3 years | +592% | +64.6M shares |
| 5 years | +1234% | +69.9M shares |
| Available history | +1808% | +71.6M shares |
TLPH has 76M diluted shares, up 82% from a year ago.
TLPH Net Leverage
TLPH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TLPH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.1 | Neutral |
| Stochastic | 5.7 | Oversold |
TLPH's weekly RSI is 46 (neutral) and its Stochastic is 6 (oversold).
TLPH PE vs Healthcare Sector
| Metric | TLPH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
TLPH has no meaningful PE right now: it lost money over the past year.
TLPH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.08 | 4.6% below |
| 20 week MA | $1.19 | 13% below |
| 50 week MA | $1.03 | 0% above |
| 100 week MA | $0.85 | 21% above |
| 200 week MA | $0.91 | 13% above |
TLPH has slipped below its 8-, 20- and 50-week averages, though it's still 13% above its 200-week average.
TLPH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $44.8 | $25.4 | -43% |
| 2021 | $25.4 | $11.2 | -56% |
| 2022 | $11.2 | $2.07 | -82% |
| 2023 | $2.07 | $0.74 | -64% |
| 2024 | $0.74 | $0.53 | -28% |
| 2025 | $0.53 | $1.10 | +108% |
| 2026 YTD | $1.10 | $1.03 | -6.4% |
TLPH's yearly returns have swung widely, from +108% in 2025 to −82% in 2022. It's down 6.4% so far in 2026.